Bluejay Diagnostics, Inc.
BJDX
$2.98
-$0.27-8.31%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.96M | 3.94M | 3.71M | 3.70M | 3.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.98M | 6.72M | 6.63M | 7.17M | 8.07M |
| Operating Income | -6.98M | -6.72M | -6.63M | -7.17M | -8.07M |
| Income Before Tax | -6.85M | -6.74M | -7.25M | -7.72M | -8.59M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.85 | -6.74 | -7.25 | -7.72 | -8.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.85M | -6.74M | -7.25M | -7.72M | -8.59M |
| EBIT | -6.98M | -6.72M | -6.63M | -7.17M | -8.07M |
| EBITDA | -6.91M | -6.65M | -6.56M | -7.09M | -7.99M |
| EPS Basic | -134.42 | -438.13 | -432.49 | -419.03 | -307.77 |
| Normalized Basic EPS | -21.27 | -38.12 | -34.59 | -26.18 | -19.39 |
| EPS Diluted | -134.42 | -438.13 | -432.49 | -419.03 | -307.77 |
| Normalized Diluted EPS | -21.27 | -38.12 | -34.59 | -26.18 | -19.39 |
| Average Basic Shares Outstanding | 1.01M | 664.80K | 318.00K | 179.50K | 47.80K |
| Average Diluted Shares Outstanding | 1.01M | 664.80K | 318.00K | 179.50K | 47.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |